SCHEMBL19670560

SCHEMBL19670560

CC(=O)c1cccc(NC(=O)N(c2nc(-c3cccc(C(F)(F)F)c3)ccc2N)C2CCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ TP53 P04637 1/20 0.41
▸ PTGS1 P23219 2/20 0.41
▸ MAPT P10636 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ LCK P06239 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ MCHR1 Q99705 1/20 0.40
▸ RHOA P61586 1/20 0.40
▸ ATR Q13535 1/20 0.40
▸ TRPV1 Q8NER1 1/20 0.40
▸ KDM1A O60341 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19706120 0.87 POLB (0.45) POLBRAB9ATP53PTGS1MAPT
SCHEMBL19365784 0.86 POLB (0.47) POLBRAB9AMCHR1RXFP1
SCHEMBL19365636 0.85 POLB (0.46) POLBRAB9AMCHR1KDM1APIK3CD
SCHEMBL19365722 0.85 POLB (0.41) POLBRAB9AMCHR1KDM1APIK3CD
SCHEMBL19365519 0.85 POLB (0.46) POLBRAB9AMAPTMCHR1
SCHEMBL19365306 0.84 POLB (0.44) POLBRAB9AMCHR1KDM1ACA12
SCHEMBL19365571 0.82 MCHR1 (0.42) POLBRAB9ALMNAMCHR1ATR
SCHEMBL19670603 0.82 POLB (0.43) POLBRAB9AMCHR1TRPV1KDM1A
SCHEMBL21841343 0.82 KMO (0.41) POLBRAB9AMCHR1TRPV1KDM1A
SCHEMBL19706137 0.82 MCHR1 (0.43) POLBRAB9ALMNALCKMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2020-03-17 — — US disclosed
US-20170355697-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2017-12-14 — — US disclosed
US-9834558-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-12-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355697-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 POLB 961/4885RAB9A 1471/4885TP53 349/4885
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators SIRT1, SIRT3, SIRT2 POLB 961/4885RAB9A 1471/4885TP53 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback